Large-scale testing (Phase 3)Study completedNCT02779764
What this trial is testing
A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) Treatment
Who this might be right for
Hemodialysis Patients With Renal Anemia
Astellas Pharma Inc 164